Abstract
Background: Peripheral neuropathy is the dose-limiting toxicity of stavudine and didanosine (nucleoside analogs used in HIV treatment) and is attributed to mitochondrial toxicity from these drugs. Acetyl L-carnitine (ALC) and co-enzyme Q10 are proposed as neuropathy treatments, but evidence to support these is limited. Methods: We examined ALC and a water-soluble formulation of co-enzyme Q10 (HQO™) for the prevention of d4T and ddI neurotoxicity using cultured fetal rat DRG as an in vitro model. Results: DdI (33μM) and d4T (50μM) caused clear toxicity (impaired neurite growth) by day 8 of DRG culture. HQO™ at concentrations 1-100μM completely prevented the toxicity of 33μM ddI in vitro and ALC at concentrations 1-100 μM substantially (but incompletely) prevented ddI toxicity in this model. In contrast, ALC was ineffective at all concentrations tested for preventing the toxicity of 50μM d4T. HQO™ showed dose-dependent efficacy for preventing d4T toxicity. HQO™ (1μM) partially prevented d4T toxicity while 10 and 100μM HQO™ completely prevented d4T toxicity in this model. Conclusions: We find HQO™ is superior to ALC for preventing the neurotoxicity of d4T (the HIV treatment most associated with neuropathy) and ddI in vitro. Further study is needed to clarify any clinical role for co-enzyme Q10 coadministration with d4T and ddI and to assess whether this compound may have a role in treating established cases of neuropathy.
Keywords: HIV, stavudine, neuropathy, coenzyme Q10, acetyl L-carnitine
Current HIV Research
Title: Ubisol-AquaTM: Coenzyme Q10 Prevents Antiretroviral Toxic Neuropathy in an In Vitro Model
Volume: 8 Issue: 3
Author(s): Catherine L. Cherry, Masqura Mobarok, Steven L. Wesselingh, Randi Fain, Shelley Weinstock, Gilda Tachedjian, Seema Srivastava, David P. Tyssen, Jonathan D. Glass and David J. Hooker
Affiliation:
Keywords: HIV, stavudine, neuropathy, coenzyme Q10, acetyl L-carnitine
Abstract: Background: Peripheral neuropathy is the dose-limiting toxicity of stavudine and didanosine (nucleoside analogs used in HIV treatment) and is attributed to mitochondrial toxicity from these drugs. Acetyl L-carnitine (ALC) and co-enzyme Q10 are proposed as neuropathy treatments, but evidence to support these is limited. Methods: We examined ALC and a water-soluble formulation of co-enzyme Q10 (HQO™) for the prevention of d4T and ddI neurotoxicity using cultured fetal rat DRG as an in vitro model. Results: DdI (33μM) and d4T (50μM) caused clear toxicity (impaired neurite growth) by day 8 of DRG culture. HQO™ at concentrations 1-100μM completely prevented the toxicity of 33μM ddI in vitro and ALC at concentrations 1-100 μM substantially (but incompletely) prevented ddI toxicity in this model. In contrast, ALC was ineffective at all concentrations tested for preventing the toxicity of 50μM d4T. HQO™ showed dose-dependent efficacy for preventing d4T toxicity. HQO™ (1μM) partially prevented d4T toxicity while 10 and 100μM HQO™ completely prevented d4T toxicity in this model. Conclusions: We find HQO™ is superior to ALC for preventing the neurotoxicity of d4T (the HIV treatment most associated with neuropathy) and ddI in vitro. Further study is needed to clarify any clinical role for co-enzyme Q10 coadministration with d4T and ddI and to assess whether this compound may have a role in treating established cases of neuropathy.
Export Options
About this article
Cite this article as:
Cherry Catherine L., Mobarok Masqura, Wesselingh Steven L., Fain Randi, Weinstock Shelley, Tachedjian Gilda, Srivastava Seema, Tyssen David P., Glass Jonathan D. and Hooker David J., Ubisol-AquaTM: Coenzyme Q10 Prevents Antiretroviral Toxic Neuropathy in an In Vitro Model, Current HIV Research 2010; 8 (3) . https://dx.doi.org/10.2174/157016210791111106
DOI https://dx.doi.org/10.2174/157016210791111106 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Physical Activity and Diabetic Cardiomyopathy: Myocardial Adaptation Depending on Exercise Load
Current Diabetes Reviews Safety Aspects of Statins: Which Factors Create the Adverse Effects of Statins
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pneumonia Due to Methicilin-Resistant Staphylococcus aureus (MRSA): A Review
Current Respiratory Medicine Reviews Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Current Drug Metabolism Passage of VIP / PACAP / Secretin Family Across the Blood-Brain Barrier: Therapeutic Effects
Current Pharmaceutical Design Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Current Pharmaceutical Design Recent Studies of Aldose Reductase Enzyme Inhibition for Diabetic Complications
Current Medicinal Chemistry Stem Cells for Microenvironmental Modulation and Retinal Regeneration
Current Tissue Engineering (Discontinued) Baroreflex Function: Determinants in Healthy Subjects and Disturbances in Diabetes, Obesity and Metabolic Syndrome
Current Diabetes Reviews Critical Limb Ischemia: Definition and Natural History
Current Drug Targets - Cardiovascular & Hematological Disorders Dysglycemia and Abdominal Obesity
Current Vascular Pharmacology Oral Delivery of Insulin Loaded into Polymeric Nanoparticles in Rats
Drug Delivery Letters Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety Review on Patents for Ubiquitin-Proteasome Inhibitor as Medical Advance in Major Human Diseases
Recent Patents on Biomedical Engineering (Discontinued) Fibrates and Microvascular Complications in Diabetes - Insight from the FIELD Study
Current Pharmaceutical Design Endothelial Effects of Drugs Designed to Treat Erectile Dysfunction
Current Pharmaceutical Design Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs
Central Nervous System Agents in Medicinal Chemistry Development of Pyrazole Compounds as Antidiabetic Agent: A Review
Letters in Drug Design & Discovery An Overview of the Actions of Capsaicin and Its Receptor, TRPV1, and Their Relations to Small Primary Sensory Neurons
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Vascular Endothelial Growth Factor Electro-Gene Therapy Improves Functional Outcome in a Mouse Model of ALS
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)